Department of Molecular Physiology and Biophysics, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America.
PLoS One. 2013 Nov 18;8(11):e79980. doi: 10.1371/journal.pone.0079980. eCollection 2013.
Translocator protein 18 kDa (TSPO) is an outer-mitochondrial membrane transporter which has many functions including participation in the mitochondrial permeability transition pore, regulation of reactive oxygen species (ROS), production of cellular energy, and is the rate-limiting step in the uptake of cholesterol. TSPO expression is dysregulated during disease pathologies involving changes in tissue energy demands such as cancer, and is up-regulated in activated macrophages during the inflammatory response. Obesity is associated with decreased energy expenditure, mitochondrial dysfunction, and chronic low-grade inflammation which collectively contribute to the development of the Metabolic Syndrome. Therefore, we hypothesized that dysregulation of TSPO in adipose tissue may be a feature of disease pathology in obesity. Radioligand binding studies revealed a significant reduction in TSPO ligand binding sites in mitochondrial extracts from both white (WAT) and brown adipose tissue (BAT) in mouse models of obesity (diet-induced and genetic) compared to control animals. We also confirmed a reduction in TSPO gene expression in whole tissue extracts from WAT and BAT. Immunohistochemistry in WAT confirmed TSPO expression in adipocytes but also revealed high-levels of TSPO expression in WAT macrophages in obese animals. No changes in TSPO expression were observed in WAT or BAT after a 17 hour fast or 4 hour cold exposure. Treatment of mice with the TSPO ligand PK11195 resulted in regulation of metabolic genes in WAT. Together, these results suggest a potential role for TSPO in mediating adipose tissue homeostasis.
转位蛋白 18kDa(TSPO)是一种外线粒体膜转运蛋白,具有多种功能,包括参与线粒体通透性转换孔、调节活性氧(ROS)、产生细胞能量,并且是胆固醇摄取的限速步骤。在涉及组织能量需求变化的疾病病理过程中,TSPO 的表达失调,如癌症,并且在炎症反应中激活的巨噬细胞中上调。肥胖与能量消耗减少、线粒体功能障碍和慢性低度炎症有关,这些因素共同导致代谢综合征的发生。因此,我们假设脂肪组织中 TSPO 的失调可能是肥胖疾病病理的一个特征。放射性配体结合研究显示,与对照动物相比,肥胖(饮食诱导和遗传)小鼠模型的白色(WAT)和棕色脂肪组织(BAT)线粒体提取物中的 TSPO 配体结合位点显著减少。我们还证实了 WAT 和 BAT 全组织提取物中 TSPO 基因表达的减少。WAT 的免疫组织化学证实了 TSPO 在脂肪细胞中的表达,但也揭示了肥胖动物 WAT 巨噬细胞中 TSPO 的高水平表达。在 17 小时禁食或 4 小时冷暴露后,WAT 或 BAT 中未观察到 TSPO 表达的变化。用 TSPO 配体 PK11195 治疗小鼠可调节 WAT 中的代谢基因。总之,这些结果表明 TSPO 在调节脂肪组织稳态方面可能发挥作用。